Alnylam Issues 2023 Corporate Responsibility ReportBusiness Wire • 4 days agoAlnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today the publication of its 2023 Corporate Responsibility Report. The company continues to take...